Press Releases Neuren Pharmaceuticals Limited

Equities

NEU

NZNEUE0001S8

Market Closed - Australian S.E. Other stock markets 02:10:53 2024-05-16 EDT			5-day change	1st Jan Change
21.8 ^AUD	+2.16%		+12.89%	-12.70%

05-09	Neuren Pharmaceuticals Partner Acadia Pharmaceuticals Posts US DAYBUE Sales of $75.9 Million	MT
04-24	Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Weekly Top Ten News Stories - 15 March 2024	03-15	AQ
Fragile X Syndrome Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)	23-10-10	AQ
Fragile X Syndrome Pipeline, Clinical Trials and NDA Approvals 2023 (Updated)	23-09-18	AQ
Headline	23-03-20	AQ
Neuren Pharmaceuticals : Investor presentation 25 Feb 2022	22-02-24	PU
Neuren Pharmaceuticals : Notification regarding unquoted securities - NEU	22-02-03	PU
Neuren Pharmaceuticals : Q4 2021 quarterly activity and cash flow report	22-01-30	PU
Neuren presenting at Bell Potter Healthcare Conference	21-11-09	PU
Neuren Pharmaceuticals : FDA Grants Orphan Drug Designation for Neuren's NNZ-2591 to Treat Angelman, Phelan-McDermid and Pitt Hopkins Syndromes	19-10-17	BU
Neuren Pharmaceuticals : Change of Director's Interest Notice	17-08-29	PU
Neuren Pharmaceuticals : Notice under section 708A(5)(e) of the Corporations Act	17-08-29	PU
Neuren Pharmaceuticals : Results of Meeting	17-08-28	PU
Neuren Pharmaceuticals : reports 2017 half-year results	17-08-24	PU
Neuren Pharmaceuticals : Notice of special meeting of shareholders	17-08-14	PU
Neuren Pharmaceuticals : Becoming a substantial holder	17-07-20	PU
Neuren Pharmaceuticals : granted Type B Meeting with FDA for Rett syndrome	17-07-19	PU
Neuren Pharmaceuticals : Notice under section 708A(5)(e) of the Corporations Act	17-07-18	PU
Neuren Pharmaceuticals : Appendix 3B	17-07-18	PU
Neuren Pharmaceuticals : Notice under section 708A(5)(e) of the Corporations Act	17-07-13	PU
Neuren Pharmaceuticals : Results of Meeting	17-06-28	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Neuren Pharmaceuticals Limited

Equities

NEU

NZNEUE0001S8

Press Releases

Filters